Mineralys Therapeutics, Inc. (MLYS)
Mineralys Therapeutics Market Cap : 2.195B for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biogen, Inc. | 25.38B |
| Syndax Pharmaceuticals, Inc. | 2.156B |
| Regeneron Pharmaceuticals, Inc. | 79.17B |
| Immunic, Inc. | 152.64M |
| Cogent Biosciences, Inc. | 5.903B |
Market Cap Related Metrics
| Price to Book Value | 3.394 |
| Price | 26.62 |
| Earnings Yield | -8.94% |